Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
246.78
+3.72 (+1.53%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,925,904
Open
243.32
Bid (Size)
246.73 (200)
Ask (Size)
246.82 (100)
Prev. Close
243.05
Today's Range
243.07 - 247.75
52wk Range
184.63 - 261.63
Shares Outstanding
N/A
Dividend Yield
2.80%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
3 Rock-Solid Dividend Stocks to Buy and Hold for Decades
↗
July 14, 2026
AbbVie, Enbridge, and Coca-Cola pay high dividends and are the types of stocks that investors can buy and forget about.
Via
The Motley Fool
Topics
Intellectual Property
Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb
↗
July 14, 2026
Drug pricing matters, but pipelines matter even more.
Via
The Motley Fool
Topics
Government
Intellectual Property
Performance
YTD
+7.6%
+7.6%
1 Month
+11.4%
+11.4%
3 Month
+17.4%
+17.4%
6 Month
+11.8%
+11.8%
1 Year
+28.9%
+28.9%
More News
Read More
3 Dividend Stocks Built for Long-Term Buy-and-Hold Investors
↗
July 13, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Cannabis Theme Rally Powered by Profitability, Not Pure-Play Speculation
↗
July 03, 2026
Via
Chartmill
Topics
Cannabis
AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty
↗
July 11, 2026
Via
The Motley Fool
Topics
Intellectual Property
5 Dividend Kings to Buy in July with Irristable Value and Yield
↗
July 08, 2026
Via
MarketBeat
3 Reasons to Buy Novo Nordisk Stock
↗
July 07, 2026
Via
The Motley Fool
U.S. Healthcare Spending Just Hit $5.7 Trillion and Continues to Grow: 2 Stocks to Buy to Profit From the Trend
↗
July 07, 2026
Via
The Motley Fool
Abivax: Wall Street Catches Up to the Data
↗
July 07, 2026
Via
MarketBeat
3 High-Yield Dividend Stocks to Buy and Hold Forever (Hint: AbbVie Makes the List)
↗
July 07, 2026
Via
The Motley Fool
Topics
Intellectual Property
The Dividend ETF Quietly Outperforming the S&P 500
↗
July 07, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
Is Apple Stock a Buy After Its Recent Pullback? Here's What History Suggests.
↗
July 07, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
3 Market-Beating Stocks Worth Investigating
July 07, 2026
Via
StockStory
Wall Street Got the Weak Jobs Report It Wanted. Chip Stocks Wrecked the Rally Anyway.
↗
July 06, 2026
Via
Chartmill
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
July 02, 2026
Via
StockStory
Topics
Artificial Intelligence
Here's How Much $1000 Invested In AbbVie 5 Years Ago Would Be Worth Today
↗
July 01, 2026
Via
Benzinga
A Nasdaq-Listed Regenerative Tissue Company Just Opened a Lab: The Next Step in Scaling a Platform Built for a NEW Aesthetics Opportunity
July 01, 2026
From
Biotech Insider
Via
GlobeNewswire
This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?
↗
June 30, 2026
Via
The Motley Fool
Topics
Intellectual Property
3 No-Brainer Dividend Stocks to Buy Right Now
↗
June 29, 2026
Via
The Motley Fool
Topics
Intellectual Property
AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
↗
June 29, 2026
Via
The Motley Fool
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
June 29, 2026
Via
StockStory
Topics
Retirement
Stocks
AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?
↗
June 25, 2026
Via
The Motley Fool
Topics
Intellectual Property
Is AbbVie a Buy After Its Purchase of Apogee?
↗
June 25, 2026
Via
The Motley Fool
The Aesthetics Giants Just Confirmed “Ozempic Face” Is Real — and a Newly Public Regenerative Player Wants to Compete for It
June 25, 2026
From
Biotech Insider
Via
GlobeNewswire
Here’s How Much You Would Have Made Owning AbbVie Stock In The Last 5 Years
↗
June 24, 2026
Via
Benzinga
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 246.78
When was AbbVie last traded?
The last trade of AbbVie was at 07/15/26 01:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.